D. E. Shaw & Co., Inc. Harvard Bioscience Inc Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.12 - $2.86 $326 - $440	-154 Reduced 0.18%	85,569 $237,000
Q3 2022 Nov 14, 2022	BUY	$2.33 - $3.92 $104,929 - $176,533	45,034 Added 110.68%	85,723 $220,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.42 $133,459 - $261,223	40,689 New	40,689 $146,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.